Pt. Rohto Laboratories Indonesia

What Pt. Rohto Laboratories Indonesia does

Pt. Rohto Laboratories Indonesia is an Indonesian-domiciled operating entity whose name indicates a Perseroan Terbatas (limited liability) structure engaged in laboratory or pharmaceutical-related activity. The only verifiable first-party signal in the supplied dataset is its web presence at rohto.co.id, an Indonesian country-code top-level domain consistent with an Indonesia-focused commercial operation. The single available source consists entirely of a website loader/verification page and explicitly contains no substantive company information: revenue is null, founding date is blank, legal name field is empty, no products or services are enumerated, no headquarters address is recorded, no management team is listed, and no parent-company or ownership linkage is confirmed. Consequently, no first-party claims about product portfolio, manufacturing footprint, distribution channels, customer segments, technology stack, or business model can be made from the supplied evidence.

Because the input provides zero functional, operational, or financial detail beyond the company name and a loading page, a substantive business description cannot be authored from the data alone. The entity's precise product lines, therapeutic or consumer-health categories, manufacturing vs. distribution orientation, and go-to-market motion are all unconfirmed. Any analysis of how the company makes money, who it sells to, and through what channels would require fresh primary sources such as company filings, press releases, distributor disclosures, or registry data — none of which are present in this dataset.

For purposes of analyst hand-off: this entity should be treated as effectively unresearched within the scope of the supplied data. The next research steps required before any investment, partnership, or competitive analysis are (i) confirm corporate identity and registration data via Indonesian company registry (AHU/OSS), (ii) identify the parent or shareholder structure, (iii) capture product catalog and pricing from the live corporate website, and (iv) obtain revenue or import-export data from Indonesian statistical or trade sources.

Name

Pt. Rohto Laboratories Indonesia

Website

https://rohto.co.id

Company type

Private

Operating status

Operating

Headcount range

251–500 employees

Short description

Pt. Rohto Laboratories Indonesia is an Indonesian-domiciled Perseroan Terbatas operating in laboratory or pharmaceutical-related activity; the supplied dataset contains no products, customers, financials, or management detail, leaving the entity effectively uncharacterized.

Ownership category

akta.pro rank

Headquarters

HQ city

Jakarta

HQ country

Indonesia

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Others

Core offering

The actual products and services offered cannot be determined from the available source content. The provided source for Pt. Rohto Laboratories Indonesia is a Cloudflare/loader verification page at rohto.co.id with no substantive description of what the company manufactures, sells, or delivers.

Differentiator

Problem solved

Functional benefit

Products and services

• Products and services cannot be determined The source content is limited to a Cloudflare/loader verification page at rohto.co.id with no information about any products or services offered by Pt. Rohto Laboratories Indonesia.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Alcon: World's largest eye-care device and consumer vision care company. Comparable to Rohto where consumer eye-drop and lens-care SKUs overlap, though Alcon's scope is considerably wider.
• PT Bayer Indonesia: Multinational consumer health and pharma subsidiary operating in Indonesia with OTC and personal care brands. Overlaps Rohto Indonesia's consumer health and OTC positioning across the same channels.
• Johnson & Johnson Indonesia: Multinational consumer health and personal care subsidiary operating in Indonesia across OTC, skincare, and eye/contact categories. Comparable to Rohto Indonesia in OTC shelf positioning and multinational subsidiary structure.
• Bausch + Lomb (Bausch Health): Global eye-health company with a large ophthalmology and consumer vision care portfolio. Overlaps Rohto's eye-care focus at a much larger scale and broader category breadth.
• PT Pfizer Indonesia: Multinational pharma subsidiary with Indonesian OTC, consumer health, and prescription operations. Comparable as an international pharma subsidiary competing in the same Indonesian regulatory and channel environment.
• PT Merck Indonesia (Merck Sharp & Dohme): Multinational pharma subsidiary in Indonesia with consumer health, OTC, and personal care presence. Comparable as an international pharma subsidiary sharing similar regulatory, channel, and demand dynamics.

Direct peers

• Kimia Farma: State-linked Indonesian pharmaceutical manufacturer and pharmacy chain operator. Comparable as a domestic pharma presence with widespread retail footprint competing for the same Indonesian OTC shelf.
• Kalbe Farma: Indonesia's largest domestic pharmaceutical and consumer health company, with broad OTC, prescription, and consumer product distribution. Closest domestic competitor to Rohto Indonesia across Indonesian pharmacy and modern trade channels.
• Tempo Scan Pacific: Indonesian-listed pharmaceutical and consumer healthcare manufacturer with deep domestic distribution. Directly competes with Rohto Indonesia in OTC and consumer pharma categories.
• Santen Pharmaceutical: Japanese-headquartered ophthalmology and consumer eye-care company. Highly comparable to Rohto Laboratories Indonesia given the shared Japanese heritage, eye-care category focus, and South/Southeast Asia distribution ambitions.

Market position

Strengths3 records

Weaknesses4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/lifeatrohtoid

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pt. Rohto Laboratories Indonesia